---
title: Intel will establish mega laboratory in Costa Rica for the validation of new products
description: Intel will establish mega laboratory in Costa Rica for the validation of new products
---

[![header-cinde.png](https://blog.cinde.org/hs-fs/hubfs/Logo%20CINDE_Logo%20English%20color.png?width=400&height=148&name=Logo%20CINDE_Logo%20English%20color.png "header-cinde.png")](https://www.cinde.org/en/)

- [Default HubSpot Blog](https://blog.cinde.org/blog)

# essential News

## [Intel will establish mega laboratory in Costa Rica for the validation of new products](https://blog.cinde.org/en/news/news/intel-will-establish-mega-laboratory-in-costa-rica-for-the-validation-of-new-products)

 Jun 10, 2014 2:00:00 AM / by [cinde.org](https://blog.cinde.org/en/author/danielgonzalez)

- [Tweet](https://twitter.com/share)

**Intel decided to consolidate its presence in Costa Rica and establish a Mega Laboratory for testing their new products. This is the first time that Intel has decided to consolidate its laboratories in a single location, making this operation the first of its kind.**

**The announcement highlights the transformation of Intel in Costa Rica and its confidence in the country, through the decision to establish a Mega Lab dedicated to product development.**

**This new project joins Intel Shared Services Center and the Center for Engineering and Development, employing 1,500 people in the country.**

**New York, USA**, June 10, 2014: The President of Costa Rica, Luis Guillermo Solís; the Minister of Foreign Trade, Alexander Mora; and the President and Director General of the Costa Rican Investment Promotion Agency (CINDE), Jose Rossi and Gabriela Llobet announced today in New York that Intel will open in Costa Rica a one-of-a-kind Mega Lab for the validation and testing of its products in development.

From the Mega Laboratory (Mega Lab), the Costa Rican technicians and engineers will be responsible for authorizing and determining the efficiency and quality of new Intel products prior to their manufacturing and distribution, setting the pace of new technology from Intel.

The operation is part of the manufacturing research and development division of Intel Corporation. The Mega Lab will employ 350 people.

The Mega Lab adds to Intel’s existing operations in Costa Rica, including the Development and Engineering Center which employs 700 Costa Ricans, and the Global Shared Services Center with approximately 800 additional employees.

Total payroll for Intel in Costa Rica will reach more than 1,500 people by the end of 2014 with potential for future growth.

Intel's decision to bring this new operation to Costa Rica was confirmed yesterday, June 9, during a meeting held between President Solis and Intel’s CEO, Brian Krzanich, at the company’s headquarters in Silicon Valley. This meeting was one component of a U.S. investment promotion mission led by President Solis and accompanied by CINDE.

The Government of Costa Rica and Intel also agreed to explore the opportunity to establish a laboratory for high-tech SMEs within Intel’s facilities in order to foster entrepreneurship, connections and knowledge transfer.

The news is the result of conversations held over the past several weeks with Intel, CINDE and the authorities in the Ministry of Foreign Trade-COMEX.

The President noted that this announcement "fills him with optimism and confirms Costa Rica’s global potential as a location for highly innovative operations in the area of

 Topics: [Press Releases](https://blog.cinde.org/en/topic/press-releases?hsLang=en)

#### Written by [cinde.org](https://blog.cinde.org/en/author/danielgonzalez)

- Recent
- Popular
- Categories

### Lists by Topic

- [Press Releases (309)](https://blog.cinde.org/en/tag/press-releases)
- [News & Articles (100)](https://blog.cinde.org/en/tag/news-and-articles)
- [Innovation (77)](https://blog.cinde.org/en/tag/innovation)
- [Corporate and Business Processes (71)](https://blog.cinde.org/en/tag/corporate-and-business-processes)
- [Customer Centricity (71)](https://blog.cinde.org/en/tag/customer-centricity)
- [Resilience (59)](https://blog.cinde.org/en/tag/resilience)
- [Technology Design (56)](https://blog.cinde.org/en/tag/technology-design)
- [Life Sciences (54)](https://blog.cinde.org/en/tag/life-sciences)
- [Critical Thinking (46)](https://blog.cinde.org/en/tag/critical-thinking)
- [Diversity & Inclusion (46)](https://blog.cinde.org/en/tag/diversity-and-inclusion)
- [Digital Technologies (41)](https://blog.cinde.org/en/tag/digital-technologies)
- [Lifelong Learning (41)](https://blog.cinde.org/en/tag/lifelong-learning)
- [Soft Skills (41)](https://blog.cinde.org/en/tag/soft-skills)
- [Featured (37)](https://blog.cinde.org/en/tag/featured)
- [R&D (37)](https://blog.cinde.org/en/tag/r-and-d)
- [Creativity (34)](https://blog.cinde.org/en/tag/creativity)
- [Manufacturing (27)](https://blog.cinde.org/en/tag/manufacturing)
- [Media (27)](https://blog.cinde.org/en/tag/media)
- [Robotics (27)](https://blog.cinde.org/en/tag/robotics)
- [3D Printing (25)](https://blog.cinde.org/en/tag/3d-printing)
- [Environmental awareness (25)](https://blog.cinde.org/en/tag/environmental-awareness)
- [Cloud (19)](https://blog.cinde.org/en/tag/cloud)
- [New Materials (18)](https://blog.cinde.org/en/tag/new-materials)
- [Cybersecurity (15)](https://blog.cinde.org/en/tag/cybersecurity)
- [Internet of Things (14)](https://blog.cinde.org/en/tag/internet-of-things)
- [Creative Industries (10)](https://blog.cinde.org/en/tag/creative-industries)
- [Intel (8)](https://blog.cinde.org/en/tag/intel)
- [UX/UI (7)](https://blog.cinde.org/en/tag/ux-ui)
- [Amazon (6)](https://blog.cinde.org/en/tag/amazon)
- [Big Data/ Analytics (5)](https://blog.cinde.org/en/tag/big-data-analytics)
- [Sykes (5)](https://blog.cinde.org/en/tag/sykes)
- [Super-featured (4)](https://blog.cinde.org/en/tag/super-featured)
- [Concentrix (3)](https://blog.cinde.org/en/tag/concentrix)
- [IBM (3)](https://blog.cinde.org/en/tag/ibm)
- [ICU Medical (3)](https://blog.cinde.org/en/tag/icu-medical)
- [Micro Technologies (3)](https://blog.cinde.org/en/tag/micro-technologies)
- [MicroVention (3)](https://blog.cinde.org/en/tag/microvention)
- [Procter & Gamble (3)](https://blog.cinde.org/en/tag/procter-and-gamble)
- [Roche (3)](https://blog.cinde.org/en/tag/roche)
- [3M (2)](https://blog.cinde.org/en/tag/3m)
- [ADMEDES (2)](https://blog.cinde.org/en/tag/admedes)
- [AI-Machine Learning (2)](https://blog.cinde.org/en/tag/ai-machine-learning)
- [Accenture (2)](https://blog.cinde.org/en/tag/accenture)
- [Autodesk (2)](https://blog.cinde.org/en/tag/autodesk)
- [BAC Credomatic (2)](https://blog.cinde.org/en/tag/bac-credomatic)
- [Bayer Business Services (2)](https://blog.cinde.org/en/tag/bayer-business-services)
- [Bayer Medical (2)](https://blog.cinde.org/en/tag/bayer-medical)
- [Boston Scientific (2)](https://blog.cinde.org/en/tag/boston-scientific)
- [East West Manufacturing (2)](https://blog.cinde.org/en/tag/east-west-manufacturing)
- [Edwards Lifesciences (2)](https://blog.cinde.org/en/tag/edwards-lifesciences)
- [Establishment Labs (2)](https://blog.cinde.org/en/tag/establishment-labs)
- [Johnson Controls (2)](https://blog.cinde.org/en/tag/johnson-controls)
- [McKinsey & Co. Support Services (2)](https://blog.cinde.org/en/tag/mckinsey-and-co-support-services)
- [Microsoft (2)](https://blog.cinde.org/en/tag/microsoft)
- [Proquinal (2)](https://blog.cinde.org/en/tag/proquinal)
- [Samtec (2)](https://blog.cinde.org/en/tag/samtec)
- [APM Terminals (1)](https://blog.cinde.org/en/tag/apm-terminals)
- [ATL Technology (1)](https://blog.cinde.org/en/tag/atl-technology)
- [Akamai (1)](https://blog.cinde.org/en/tag/akamai)
- [Allergan (1)](https://blog.cinde.org/en/tag/allergan)
- [Amazon Web Services (1)](https://blog.cinde.org/en/tag/amazon-web-services)
- [Analytics (1)](https://blog.cinde.org/en/tag/analytics)
- [AstraZeneca (1)](https://blog.cinde.org/en/tag/astrazeneca)
- [Automation (1)](https://blog.cinde.org/en/tag/automation)
- [Automation/RPA (1)](https://blog.cinde.org/en/tag/automation-rpa)
- [Bacardi (1)](https://blog.cinde.org/en/tag/bacardi)
- [Bayer (1)](https://blog.cinde.org/en/tag/bayer)
- [Bill Gosling (1)](https://blog.cinde.org/en/tag/bill-gosling)
- [Biomerics (1)](https://blog.cinde.org/en/tag/biomerics)
- [Blockchain (1)](https://blog.cinde.org/en/tag/blockchain)
- [British American Tobacco (1)](https://blog.cinde.org/en/tag/british-american-tobacco)
- [Byte (1)](https://blog.cinde.org/en/tag/byte)
- [CSS Corp (1)](https://blog.cinde.org/en/tag/css-corp)
- [Cloudera (1)](https://blog.cinde.org/en/tag/cloudera)
- [Emerson (1)](https://blog.cinde.org/en/tag/emerson)
- [Encore (1)](https://blog.cinde.org/en/tag/encore)
- [Equifax (1)](https://blog.cinde.org/en/tag/equifax)
- [Eurofins (1)](https://blog.cinde.org/en/tag/eurofins)
- [Evonik (1)](https://blog.cinde.org/en/tag/evonik)
- [Fiserv (1)](https://blog.cinde.org/en/tag/fiserv)
- [Fujitsu (1)](https://blog.cinde.org/en/tag/fujitsu)
- [GEP (1)](https://blog.cinde.org/en/tag/gep)
- [GSK Glaxo Smith Kline (1)](https://blog.cinde.org/en/tag/gsk-glaxo-smith-kline)
- [Gensler (1)](https://blog.cinde.org/en/tag/gensler)
- [HP Inc. (1)](https://blog.cinde.org/en/tag/hp-inc)
- [Helm 360 (1)](https://blog.cinde.org/en/tag/helm-360)
- [Hologic (1)](https://blog.cinde.org/en/tag/hologic)
- [Instantia (1)](https://blog.cinde.org/en/tag/instantia)
- [Kimberly Clark (1)](https://blog.cinde.org/en/tag/kimberly-clark)
- [Medtronic (1)](https://blog.cinde.org/en/tag/medtronic)
- [Moody's Investor Services (1)](https://blog.cinde.org/en/tag/moodys-investor-services)
- [NACS (1)](https://blog.cinde.org/en/tag/nacs)
- [NI (1)](https://blog.cinde.org/en/tag/ni)
- [Nevro (1)](https://blog.cinde.org/en/tag/nevro)
- [Palo Alto Networks (1)](https://blog.cinde.org/en/tag/palo-alto-networks)
- [Panasonic (1)](https://blog.cinde.org/en/tag/panasonic)
- [Pharma (1)](https://blog.cinde.org/en/tag/pharma)
- [Philips (1)](https://blog.cinde.org/en/tag/philips)
- [Prent (1)](https://blog.cinde.org/en/tag/prent)
- [Qorvo (1)](https://blog.cinde.org/en/tag/qorvo)
- [Resonetics (1)](https://blog.cinde.org/en/tag/resonetics)
- [SMC (1)](https://blog.cinde.org/en/tag/smc)
- [Smile Direct (1)](https://blog.cinde.org/en/tag/smile-direct)
- [Softtek (1)](https://blog.cinde.org/en/tag/softtek)
- [Synter (1)](https://blog.cinde.org/en/tag/synter)
- [Teleperformance (1)](https://blog.cinde.org/en/tag/teleperformance)
- [Teradyne (1)](https://blog.cinde.org/en/tag/teradyne)
- [TradeStation (1)](https://blog.cinde.org/en/tag/tradestation)
- [VMware (1)](https://blog.cinde.org/en/tag/vmware)
- [VR-AR (1)](https://blog.cinde.org/en/tag/vr-ar)
- [Viant (1)](https://blog.cinde.org/en/tag/viant)
- [Viatris (1)](https://blog.cinde.org/en/tag/viatris)
- [WeWork (1)](https://blog.cinde.org/en/tag/wework)
- [Wellbeing (1)](https://blog.cinde.org/en/tag/wellbeing)
- [Yellow Pallet (1)](https://blog.cinde.org/en/tag/yellow-pallet)

see all

### Posts by Topic

- [Press Releases (309)](https://blog.cinde.org/en/tag/press-releases)
- [News & Articles (100)](https://blog.cinde.org/en/tag/news-and-articles)
- [Innovation (77)](https://blog.cinde.org/en/tag/innovation)
- [Corporate and Business Processes (71)](https://blog.cinde.org/en/tag/corporate-and-business-processes)
- [Customer Centricity (71)](https://blog.cinde.org/en/tag/customer-centricity)
- [Resilience (59)](https://blog.cinde.org/en/tag/resilience)
- [Technology Design (56)](https://blog.cinde.org/en/tag/technology-design)
- [Life Sciences (54)](https://blog.cinde.org/en/tag/life-sciences)
- [Critical Thinking (46)](https://blog.cinde.org/en/tag/critical-thinking)
- [Diversity & Inclusion (46)](https://blog.cinde.org/en/tag/diversity-and-inclusion)
- [Digital Technologies (41)](https://blog.cinde.org/en/tag/digital-technologies)
- [Lifelong Learning (41)](https://blog.cinde.org/en/tag/lifelong-learning)
- [Soft Skills (41)](https://blog.cinde.org/en/tag/soft-skills)
- [Featured (37)](https://blog.cinde.org/en/tag/featured)
- [R&D (37)](https://blog.cinde.org/en/tag/r-and-d)
- [Creativity (34)](https://blog.cinde.org/en/tag/creativity)
- [Manufacturing (27)](https://blog.cinde.org/en/tag/manufacturing)
- [Media (27)](https://blog.cinde.org/en/tag/media)
- [Robotics (27)](https://blog.cinde.org/en/tag/robotics)
- [3D Printing (25)](https://blog.cinde.org/en/tag/3d-printing)
- [Environmental awareness (25)](https://blog.cinde.org/en/tag/environmental-awareness)
- [Cloud (19)](https://blog.cinde.org/en/tag/cloud)
- [New Materials (18)](https://blog.cinde.org/en/tag/new-materials)
- [Cybersecurity (15)](https://blog.cinde.org/en/tag/cybersecurity)
- [Internet of Things (14)](https://blog.cinde.org/en/tag/internet-of-things)
- [Creative Industries (10)](https://blog.cinde.org/en/tag/creative-industries)
- [Intel (8)](https://blog.cinde.org/en/tag/intel)
- [UX/UI (7)](https://blog.cinde.org/en/tag/ux-ui)
- [Amazon (6)](https://blog.cinde.org/en/tag/amazon)
- [Big Data/ Analytics (5)](https://blog.cinde.org/en/tag/big-data-analytics)
- [Sykes (5)](https://blog.cinde.org/en/tag/sykes)
- [Super-featured (4)](https://blog.cinde.org/en/tag/super-featured)
- [Concentrix (3)](https://blog.cinde.org/en/tag/concentrix)
- [IBM (3)](https://blog.cinde.org/en/tag/ibm)
- [ICU Medical (3)](https://blog.cinde.org/en/tag/icu-medical)
- [Micro Technologies (3)](https://blog.cinde.org/en/tag/micro-technologies)
- [MicroVention (3)](https://blog.cinde.org/en/tag/microvention)
- [Procter & Gamble (3)](https://blog.cinde.org/en/tag/procter-and-gamble)
- [Roche (3)](https://blog.cinde.org/en/tag/roche)
- [3M (2)](https://blog.cinde.org/en/tag/3m)
- [ADMEDES (2)](https://blog.cinde.org/en/tag/admedes)
- [AI-Machine Learning (2)](https://blog.cinde.org/en/tag/ai-machine-learning)
- [Accenture (2)](https://blog.cinde.org/en/tag/accenture)
- [Autodesk (2)](https://blog.cinde.org/en/tag/autodesk)
- [BAC Credomatic (2)](https://blog.cinde.org/en/tag/bac-credomatic)
- [Bayer Business Services (2)](https://blog.cinde.org/en/tag/bayer-business-services)
- [Bayer Medical (2)](https://blog.cinde.org/en/tag/bayer-medical)
- [Boston Scientific (2)](https://blog.cinde.org/en/tag/boston-scientific)
- [East West Manufacturing (2)](https://blog.cinde.org/en/tag/east-west-manufacturing)
- [Edwards Lifesciences (2)](https://blog.cinde.org/en/tag/edwards-lifesciences)
- [Establishment Labs (2)](https://blog.cinde.org/en/tag/establishment-labs)
- [Johnson Controls (2)](https://blog.cinde.org/en/tag/johnson-controls)
- [McKinsey & Co. Support Services (2)](https://blog.cinde.org/en/tag/mckinsey-and-co-support-services)
- [Microsoft (2)](https://blog.cinde.org/en/tag/microsoft)
- [Proquinal (2)](https://blog.cinde.org/en/tag/proquinal)
- [Samtec (2)](https://blog.cinde.org/en/tag/samtec)
- [APM Terminals (1)](https://blog.cinde.org/en/tag/apm-terminals)
- [ATL Technology (1)](https://blog.cinde.org/en/tag/atl-technology)
- [Akamai (1)](https://blog.cinde.org/en/tag/akamai)
- [Allergan (1)](https://blog.cinde.org/en/tag/allergan)
- [Amazon Web Services (1)](https://blog.cinde.org/en/tag/amazon-web-services)
- [Analytics (1)](https://blog.cinde.org/en/tag/analytics)
- [AstraZeneca (1)](https://blog.cinde.org/en/tag/astrazeneca)
- [Automation (1)](https://blog.cinde.org/en/tag/automation)
- [Automation/RPA (1)](https://blog.cinde.org/en/tag/automation-rpa)
- [Bacardi (1)](https://blog.cinde.org/en/tag/bacardi)
- [Bayer (1)](https://blog.cinde.org/en/tag/bayer)
- [Bill Gosling (1)](https://blog.cinde.org/en/tag/bill-gosling)
- [Biomerics (1)](https://blog.cinde.org/en/tag/biomerics)
- [Blockchain (1)](https://blog.cinde.org/en/tag/blockchain)
- [British American Tobacco (1)](https://blog.cinde.org/en/tag/british-american-tobacco)
- [Byte (1)](https://blog.cinde.org/en/tag/byte)
- [CSS Corp (1)](https://blog.cinde.org/en/tag/css-corp)
- [Cloudera (1)](https://blog.cinde.org/en/tag/cloudera)
- [Emerson (1)](https://blog.cinde.org/en/tag/emerson)
- [Encore (1)](https://blog.cinde.org/en/tag/encore)
- [Equifax (1)](https://blog.cinde.org/en/tag/equifax)
- [Eurofins (1)](https://blog.cinde.org/en/tag/eurofins)
- [Evonik (1)](https://blog.cinde.org/en/tag/evonik)
- [Fiserv (1)](https://blog.cinde.org/en/tag/fiserv)
- [Fujitsu (1)](https://blog.cinde.org/en/tag/fujitsu)
- [GEP (1)](https://blog.cinde.org/en/tag/gep)
- [GSK Glaxo Smith Kline (1)](https://blog.cinde.org/en/tag/gsk-glaxo-smith-kline)
- [Gensler (1)](https://blog.cinde.org/en/tag/gensler)
- [HP Inc. (1)](https://blog.cinde.org/en/tag/hp-inc)
- [Helm 360 (1)](https://blog.cinde.org/en/tag/helm-360)
- [Hologic (1)](https://blog.cinde.org/en/tag/hologic)
- [Instantia (1)](https://blog.cinde.org/en/tag/instantia)
- [Kimberly Clark (1)](https://blog.cinde.org/en/tag/kimberly-clark)
- [Medtronic (1)](https://blog.cinde.org/en/tag/medtronic)
- [Moody's Investor Services (1)](https://blog.cinde.org/en/tag/moodys-investor-services)
- [NACS (1)](https://blog.cinde.org/en/tag/nacs)
- [NI (1)](https://blog.cinde.org/en/tag/ni)
- [Nevro (1)](https://blog.cinde.org/en/tag/nevro)
- [Palo Alto Networks (1)](https://blog.cinde.org/en/tag/palo-alto-networks)
- [Panasonic (1)](https://blog.cinde.org/en/tag/panasonic)
- [Pharma (1)](https://blog.cinde.org/en/tag/pharma)
- [Philips (1)](https://blog.cinde.org/en/tag/philips)
- [Prent (1)](https://blog.cinde.org/en/tag/prent)
- [Qorvo (1)](https://blog.cinde.org/en/tag/qorvo)
- [Resonetics (1)](https://blog.cinde.org/en/tag/resonetics)
- [SMC (1)](https://blog.cinde.org/en/tag/smc)
- [Smile Direct (1)](https://blog.cinde.org/en/tag/smile-direct)
- [Softtek (1)](https://blog.cinde.org/en/tag/softtek)
- [Synter (1)](https://blog.cinde.org/en/tag/synter)
- [Teleperformance (1)](https://blog.cinde.org/en/tag/teleperformance)
- [Teradyne (1)](https://blog.cinde.org/en/tag/teradyne)
- [TradeStation (1)](https://blog.cinde.org/en/tag/tradestation)
- [VMware (1)](https://blog.cinde.org/en/tag/vmware)
- [VR-AR (1)](https://blog.cinde.org/en/tag/vr-ar)
- [Viant (1)](https://blog.cinde.org/en/tag/viant)
- [Viatris (1)](https://blog.cinde.org/en/tag/viatris)
- [WeWork (1)](https://blog.cinde.org/en/tag/wework)
- [Wellbeing (1)](https://blog.cinde.org/en/tag/wellbeing)
- [Yellow Pallet (1)](https://blog.cinde.org/en/tag/yellow-pallet)

See all

### Recent Posts

# About Us

Use this little footer to reinforce your message about who you are and why people love working with you. And since this is a global module, you only have to edit it once to make the changes across every page it appears on.

[Learn More](https://www.hubspot.com)

# Links

# Contact Us

 (+506) 2201-2800

[yourname@company.com](mailto:yourname@company.com)

 Torre Universal, Piso 22,  
La Sabana   
 Mata Redonda, San José 10108

Copyright 2026 | Designed with  by [HubSpot](https://www.hubspot.com)